Literature DB >> 88528

Falsely positive specific human chorionic gonadotropin assays in patients with testicular tumors: conversion to negative with testosterone administration.

W J Catalona, J L Vaitukaitis, W R Fair.   

Abstract

We report false elevations of serum human chorionic gonadotropin levels in 4 patients with testicular germ cell tumors. Elevated circulating luteinizing hormone levels that resulted from unilateral orchiectomy were responsible for the falsely positive human chorionic gonadotropin activity measured in commercial radioimmunoassays. In 3 patients tested aliquots of serum evaluated in reliable human chorionic gonadotropin assay systems revealed no elevation. We administered testosterone to 3 patients who had elevations of luteinizing hormone and human chorionic gonadotropin levels. Luteinizing hormone was suppress-d to normal levels 1 week later in 2 patients and in 1 it was diminished but still slightly elevated. In all 3 cases the falsely positive human chorionic gonadotropin results converted to negative. Recognition of falsely positive elevations of human chorionic gonadotropin can spare patients unnecessary operations and/or chemotherapy.

Entities:  

Mesh:

Substances:

Year:  1979        PMID: 88528     DOI: 10.1016/s0022-5347(17)56283-7

Source DB:  PubMed          Journal:  J Urol        ISSN: 0022-5347            Impact factor:   7.450


  3 in total

Review 1.  Late relapse of testis cancer.

Authors:  Yaron Ehrlich; Eli Rosenbaum; Jack Baniel
Journal:  Curr Urol Rep       Date:  2013-10       Impact factor: 3.092

2.  The usefulness of testosterone administration in identifying false-positive elevation of serum human chorionic gonadotropin in patients with germ cell tumor.

Authors:  Akitoshi Takizawa; Koji Kawai; Takashi Kawahara; Takahiro Kojima; Satoru Maruyama; Nobuo Shinohara; Shusuke Akamatsu; Tomomi Kamba; Terukazu Nakamura; Osamu Ukimura; Ryosuke Jikuya; Takeshi Kishida; Kenichi Kakimoto; Kazuo Nishimura; Toru Harabayashi; Satoshi Nagamori; Shinichi Yamashita; Yoichi Arai; Yoshitomo Sawada; Noritoshi Sekido; Hidefumi Kinoshita; Tadashi Matsuda; Tohru Nakagawa; Yukio Homma; Hiroyuki Nishiyama
Journal:  J Cancer Res Clin Oncol       Date:  2017-09-13       Impact factor: 4.553

3.  Postoperative reduction of serum beta-HCG in testicular seminoma.

Authors:  S Sakashita; T Demura; T Gotoh; A Maru; T Koyanagi
Journal:  Int Urol Nephrol       Date:  1988       Impact factor: 2.370

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.